CG
ASMB icon

Cutler Group’s Assembly Biosciences ASMB Stock Holding History

Cutler Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-125
Closed -$3K – 3983
2019
Q4 		$3K Buy
+125
New +$23K ﹤0.01% 3237
2018
Q4 		– Sell
-192
Closed -$5K – 3899
2018
Q3 		$5K Buy
192
+67
+54% +$31.4K ﹤0.01% 3012
2018
Q2 		$5K Buy
125
+42
+51% +$22.2K ﹤0.01% 3075
2018
Q1 		$1K Sell
83
-134
-62% -$83.1K ﹤0.01% 3961
2017
Q4 		$41K Buy
+217
New +$98.2K ﹤0.01% 2015
2017
Q3 		– Sell
-908
Closed -$17K – 5814
2017
Q2 		$17K Buy
+908
New +$256K ﹤0.01% 3567

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cutler Group's ASMB Position: Q3 2022 in Review

Cutler Group sold out of Assembly Biosciences (ASMB) in Q3 2022, closing a stake of 17 shares.

Cutler Group first reported a position in ASMB in Q3 2017 and held it in 17 quarters. The position peaked at $171K in Q4 2018. 50 funds tracked by Wall St. Rank hold ASMB as of Q3 2022.

  • Cutler Group reported no remaining Assembly Biosciences position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 17 Assembly Biosciences shares in Q3 2022.
  • Cutler Group first reported a position in Assembly Biosciences in Q3 2017 and held it in 17 quarters.
  • Cutler Group's Assembly Biosciences position peaked at $171K in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.